Drug Enforcement D-0217-2025

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Status

Terminated

Classification

Class II

Report Date

February 12, 2025

Termination Date

July 17, 2025

Product Information

Product description
Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.
Product quantity
247 blister packs
Reason for recall
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
FL

Location & Firm

Recalling firm
RemedyRepack Inc.
Address
625 Kolter Dr Ste 4

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0217-2025
Event ID
96191
Recall initiation date
January 24, 2025
Center classification date
February 3, 2025
Code info
Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.
More code info